Literature DB >> 7544142

Neuroantibodies: ectopic expression of a recombinant anti-substance P antibody in the central nervous system of transgenic mice.

P Piccioli1, A Di Luzio, R Amann, R Schuligoi, M A Surani, J Donnerer, A Cattaneo.   

Abstract

Recombinant antibodies are efficiently secreted by cells of the nervous system. Thus, their local expression in the CNS of transgenic mice could be used to perturb the function of the corresponding antigen. As a first application of this approach, we have generated transgenic mice that express antibodies against the neuropeptide substance P, under the transcriptional control of the promoter of the neuronal gene vgf. The transgenic antibodies are expressed in a tissue-specific and developmentally regulated manner and are effective in competing with the endogenous substance P, as demonstrated by a marked inhibition of neurogenic inflammation and by motor deficits. This phenotypic knockout approach may provide a complementary alternative to gene knockout by homologous recombination.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7544142     DOI: 10.1016/0896-6273(95)90041-1

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  10 in total

Review 1.  On the molecular basis linking Nerve Growth Factor (NGF) to Alzheimer's disease.

Authors:  Simona Capsoni; Antonino Cattaneo
Journal:  Cell Mol Neurobiol       Date:  2006-08-31       Impact factor: 5.046

2.  Immunosympathectomy as the first phenotypic knockout with antibodies.

Authors:  Antonino Cattaneo
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-20       Impact factor: 11.205

Review 3.  Production of transgenic rodents by the microinjection of cloned DNA into fertilized one-cell eggs.

Authors:  S L Si-Hoe; S Wells; D Murphy
Journal:  Mol Biotechnol       Date:  2001-02       Impact factor: 2.695

4.  Functional blockade of tyrosine kinase A in the rat basal forebrain by a novel antagonistic anti-receptor monoclonal antibody.

Authors:  A Cattaneo; S Capsoni; E Margotti; M Righi; E Kontsekova; P Pavlik; P Filipcik; M Novak
Journal:  J Neurosci       Date:  1999-11-15       Impact factor: 6.167

5.  Dissecting the involvement of tropomyosin-related kinase A and p75 neurotrophin receptor signaling in NGF deficit-induced neurodegeneration.

Authors:  Simona Capsoni; Cecilia Tiveron; Domenico Vignone; Gianluca Amato; Antonino Cattaneo
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-21       Impact factor: 11.205

6.  Alzheimer-like neurodegeneration in aged antinerve growth factor transgenic mice.

Authors:  S Capsoni; G Ugolini; A Comparini; F Ruberti; N Berardi; A Cattaneo
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

7.  Phenotypic knockout of nerve growth factor in adult transgenic mice reveals severe deficits in basal forebrain cholinergic neurons, cell death in the spleen, and skeletal muscle dystrophy.

Authors:  F Ruberti; S Capsoni; A Comparini; E Di Daniel; J Franzot; S Gonfloni; G Rossi; N Berardi; A Cattaneo
Journal:  J Neurosci       Date:  2000-04-01       Impact factor: 6.167

Review 8.  Processing, distribution, and function of VGF, a neuronal and endocrine peptide precursor.

Authors:  Andrea Levi; Gian-Luca Ferri; Elizabeth Watson; Roberta Possenti; Stephen R J Salton
Journal:  Cell Mol Neurobiol       Date:  2004-08       Impact factor: 5.046

9.  Interplay of the E box, the cyclic AMP response element, and HTF4/HEB in transcriptional regulation of the neurospecific, neurotrophin-inducible vgf gene.

Authors:  G Di Rocco; M Pennuto; B Illi; N Canu; G Filocamo; E Trani; A M Rinaldi; R Possenti; G Mandolesi; M I Sirinian; R Jucker; A Levi; S Nasi
Journal:  Mol Cell Biol       Date:  1997-03       Impact factor: 4.272

Review 10.  Neuroendocrine Role for VGF.

Authors:  Jo E Lewis; John M Brameld; Preeti H Jethwa
Journal:  Front Endocrinol (Lausanne)       Date:  2015-02-02       Impact factor: 5.555

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.